Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656951 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists
12/02/2003US6656950 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
12/02/2003US6656947 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
12/02/2003US6656943 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
12/02/2003US6656941 Altering the signal-transducing activity of GABAA receptors; diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and seizure disorders
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656930 Aralkyl diazabicycloalkane derivatives for CNS disorders
12/02/2003US6656729 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656510 Antidepressants
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656473 Defatted meal from squash seeds containing protein-bound tryptophan and carbohydrate source (glucose, maltose, sucrose) for facilitating transport across the blood brain barrier; useful for inducing sleep
12/02/2003US6656469 Treatment of nicotine dependence from tobacco products
12/02/2003CA2287046C Novel dihydroquinoline and tetrahydroquinoline compounds, process for preparing them and pharmaceutical compositions containing them
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2249756C New indanol compounds, their preparation process and the pharmaceutical compositions containing them
12/02/2003CA2248317C Anticonvulsant enantiomeric amino acid derivatives
12/02/2003CA2132865C Transdermal administration of oxybutynin
11/2003
11/27/2003WO2003098385A2 System and method for transparent early detection, warning, and intervention during a medical procedure
11/27/2003WO2003097691A1 Sodium channel regulators and modulators
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097670A1 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097656A2 Novel substituted sulfamate anticonvulsant derivatives
11/27/2003WO2003097643A1 Substituted ring-fused imidazole derivates: gabaa receptor ligands
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097637A1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
11/27/2003WO2003097636A1 Novel compounds and their use
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097623A1 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent
11/27/2003WO2003097620A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/27/2003WO2003097611A1 Novel imidazole compounds, method for preparing same and use thereof as medicines
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097564A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003WO2003097109A1 Improvements in delivery technology
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097085A1 Ddah modulators in the treatment of pain
11/27/2003WO2003097084A1 Ddah modulators in the treatment of pain
11/27/2003WO2003097082A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097069A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003WO2003097067A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097058A1 New pharmaceutical compositions containing flibanserin polymorph a
11/27/2003WO2003097057A1 Synergistic combination of an opioid analgesic and a nsaid
11/27/2003WO2003097056A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097051A2 Use of compounds that are effective as selective opiate receptor modulators
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003097043A1 Treatment of neuropathic pain
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097032A1 Means for weaning people off smoking and alcohol
11/27/2003WO2003097030A1 Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
11/27/2003WO2003097024A1 Methods for the prevention and/or the treatment of neurological disorders
11/27/2003WO2003097023A1 The use of the inhibitor transmitter of ϝ-aminobutyric acid (gaba) in the manufacture of analgesic
11/27/2003WO2003096980A2 Bicyclic modulators of androgen receptor function
11/27/2003WO2003096964A2 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
11/27/2003WO2003084464A3 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
11/27/2003WO2003078361B1 Controlling chemical reactions by spectral chemistry and spectral conditioning
11/27/2003WO2003066594A3 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003063876A3 Methods of treating patients suffering from movement disorders
11/27/2003WO2003056899A3 Nitric oxide donors for treatment of disease and injury
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003053336A3 Methods for the treatment of peripheral neural and vascular ailments
11/27/2003WO2003039446A3 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003022852A3 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003015713A3 Treatment of glial tumors with glutamate antagonists
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003011846A3 Process for the preparation of 5-substituted isobenzofurans
11/27/2003WO2003007802A3 Pharmaceutical combinations of oxycodone and naloxone
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002079170A3 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 1833